Collectively, these results highlighted that by activating the PI3K/AKT/mTOR and MAPK signaling pathways, CD157-mediated intracellular signals can contrast spontaneous apoptosis in primary AML cells ex vivo and promote cell survival. Here, AKT1 is linked to acute myeloid leukemia.